Oncologic outcomes of human papillomavirus–associated oropharynx carcinoma treated with surgery alone: A 12‐institution study of 344 patients

The oncologic outcomes of surgery alone for patients with American Joint Committee on Cancer 7th edition (AJCC 7th) pN2a and pN2b human papillomavirus–associated oropharynx squamous cell carcinoma (HPV+OPSCC) are not clear.

• Publication year

  2021

• Venue

  Cancer

• Publication date

  2021-05-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/cncr.33611PMID 33957701
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of surgical margins on local control in patients undergoing single-modality transoral robotic surgery for HPV-related oropharyngeal squamous cell carcinoma.

  2021cited by this paper
• Predicting Adverse Histopathology and Need for Postsurgical Adjuvant Therapy for Human Papilloma Virus–Associated Oropharynx Carcinoma

  2021cited by this paper
• The association of smoking and outcomes in HPV-positive oropharyngeal cancer: A systematic review.

  2020cited by this paper
• Comparing national practice versus standard guidelines for the use of adjuvant treatment following robotic surgery for oropharyngeal squamous cell carcinoma

  2020cited by this paper
• Evaluating the impact of smoking on disease‐specific survival outcomes in patients with human papillomavirus–associated oropharyngeal cancer treated with transoral robotic surgery

  2020cited by this paper
• Practice patterns and outcomes following radiation dose de‐escalation for oropharyngeal cancer

  2020cited by this paper
• Treatment modality impact on quality of life for human papillomavirus–associated oropharynx cancer

  2020cited by this paper
• Extranodal extension is a strong prognosticator in HPV‐positive oropharyngeal squamous cell carcinoma

  2020cited by this paper
• Tumor‐infiltrating lymphocyte quantification stratifies early‐stage human papillomavirus oropharynx cancer prognosis

  2020cited by this paper
• Human papillomavirus oropharynx carcinoma: Aggressive de‐escalation of adjuvant therapy

  2020cited by this paper
• Complications of Transoral Robotic Surgery.

  2020cited by this paper
• Predictors of Mortality in HPV‐Associated Oropharynx Carcinoma Treated With Surgery Alone

  2020cited by this paper
• Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311).

  2020cited by this paper
• Risk and Rate of Occult Contralateral Nodal Disease in Surgically Treated Patients With Human Papillomavirus-Related Squamous Cell Carcinoma of the Base of the Tongue.

  2019cited by this paper
• A Phase II Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed Following Transoral Robotic Surgery for Human Papilloma Virus Related Squamous Cell Carcinoma of the Oropharynx.

  2019cited by this paper
• Dose-volume Derived Nomogram as a Reliable Predictor of Radiotherapy-induced Hypothyroidism in Head and Neck Cancer Patients

  2019cited by this paper
• Systematic Review of Validated Quality of Life and Swallow Outcomes after Transoral Robotic Surgery

  2019cited by this paper
• NRG-HN002: A Randomized Phase II Trial for Patients With p16-Positive, Non-Smoking-Associated, Locoregionally Advanced Oropharyngeal Cancer

  2019cited by this paper
• Redefining Patients at Risk of Contralateral Neck Disease for HPV-related Oropharyngeal Cancer: A Pathologic Study of Patients with Bilateral Neck Dissection

  2019cited by this paper
• Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.

  2019cited by this paper
• Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States

  2019cited by this paper
• De-Escalation Strategies in HPV-Associated Oropharynx Cancer-Are we Putting the Cart Before the Horse?

  2019cited by this paper
• Occult contralateral nodal disease in oropharyngeal squamous cell carcinoma patients undergoing primary TORS with bilateral neck dissection.

  2019cited by this paper
• Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma.

  2018cited by this paper
• Quality of life outcomes of transoral robotic surgery with or without adjuvant therapy for oropharyngeal cancer

  2018cited by this paper
• AJCC-8ed nodal staging does not predict outcomes in surgically managed HPV-associated oropharyngeal cancer.

  2018cited by this paper
• Long‐term analysis of transorally resected p16 + Oropharynx cancer: Outcomes and prognostic factors

  2018cited by this paper
• Utilization of Transoral Robotic Surgery (TORS) in patients with Oropharyngeal Squamous Cell Carcinoma and its impact on survival and use of chemotherapy.

  2018cited by this paper
• Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity‐modulated radiotherapy

  2017cited by this paper
• Transoral Resection of Human Papillomavirus (HPV)-Positive Squamous Cell Carcinoma of the Oropharynx: Outcomes with and Without Adjuvant Therapy

  2017cited by this paper
• Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists.

  2017cited by this paper
• Long-term toxicities in 10-year survivors of radiation treatment for head and neck cancer.

  2017cited by this paper
• A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma

  2017cited by this paper
• Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation.

  2016cited by this paper
• Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base.

  2016cited by this paper
• Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.

  2016cited by this paper
• Survival and Gastrostomy Prevalence in Patients With Oropharyngeal Cancer Treated With Transoral Robotic Surgery vs Chemoradiotherapy.

  2016cited by this paper
• Management of Oropharyngeal Cancer in the HPV Era.

  2016cited by this paper
• Functional outcomes after TORS for oropharyngeal cancer: a systematic review

  2015cited by this paper
• HPV-Positive Oropharyngeal Carcinoma

  2015cited by this paper
• High metastatic node number, not extracapsular spread or N-classification is a node-related prognosticator in transorally-resected, neck-dissected p16-positive oropharynx cancer.

  2015cited by this paper
• Transoral endoscopic surgery: new surgical techniques for oropharyngeal cancer.

  2012cited by this paper
• Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local control.

  2012cited by this paper
• Long-term functional and oncologic results of transoral robotic surgery for oropharyngeal squamous cell carcinoma.

  2012cited by this paper
• The Mutational Landscape of Head and Neck Squamous Cell Carcinoma

  2011cited by this paper
• Human papillomavirus and survival of patients with oropharyngeal cancer.

  2010cited by this paper
• Oropharyngeal cancer: a case for single modality treatment with transoral laser microsurgery.

  2009cited by this paper
• Comparison of clinical and pathological staging in head and neck squamous cell carcinoma: results from Intergroup Study ECOG 4393/RTOG 9614.

  2009cited by this paper
• Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

  2008cited by this paper
• Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis.

  2008cited by this paper
• Treatment of oral and oropharyngeal epidermoid carcinomas by means of CO2 laser.

  2004cited by this paper
• Complications of neck dissection

  2003cited by this paper
• Squamous cell carcinoma of the oropharynx

  2002cited by this paper
• Resection of Cancer of the Tongue Base and Tonsil via the Transhyoid Approach

  2000cited by this paper
• Radiation induced sarcoma of the head and neck

  1999cited by this paper

• Oncologic Outcomes of Transoral Robotic Surgery in HPV‐Associated OPSCC: A Systematic Review and Meta‐Analysis

  2026cites this paper
• Improved Survival of HPV-Related Sinonasal Squamous Cell Carcinoma With Chemoradiation Treatment.

  2026cites this paper
• Transoral Robotic Surgery in the Multidisciplinary Care of Patients With Oropharyngeal Squamous Cell Carcinoma: ASCO Guideline

  2025cites this paper
• Transoral Robotic Surgery in the Multidisciplinary Care of Patients With Oropharyngeal Squamous Cell Carcinoma: ASCO Guideline Clinical Insights.

  2025cites this paper
• Impact of Margins on Outcomes in HPV‐Related Oropharyngeal Squamous Cell Carcinoma Treated With Surgery Only

  2025cites this paper
• Trends and Future Directions in Margin Analysis for Head and Neck Cancers.

  2024cites this paper
• Radiation Therapy for HPV-Positive Oropharyngeal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline.

  2024cites this paper
• Association of adjuvant radiation and survival in human papilloma virus‐positive oropharynx squamous cell carcinoma with lymphovascular invasion as the sole adverse pathologic feature

  2024cites this paper
• The Lack of Standardized Outcomes for Surgical Salvage of HPV-Positive Recurrent Oropharyngeal Squamous Cell Carcinoma: A Systematic Scoping Review

  2023cites this paper
• Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary Review

  2023cites this paper
• Transoral Surgery in HPV‐Positive Oropharyngeal Carcinoma: Oncologic Outcomes in the Veterans Affairs System

  2023cites this paper
• Treatment Modality Impact on Patient‐Reported Quality of Life in Human Papilloma Virus‐Associated Oropharyngeal Carcinoma

  2023cites this paper
• Detectable Post-operative Circulating Tumor Human Papillomavirus (HPV) DNA And Association with Recurrence in Patients with HPV-Associated Oropharyngeal Squamous Cell Carcinoma.

  2022cites this paper
• Treatment outcomes and radiotherapy deintensification strategies in human papillomavirus-associated tonsil cancer

  2022cites this paper
• Distant metastases in human papillomavirus‐related oropharyngeal squamous cell carcinoma: Systematic review and meta‐analysis

  2022cites this paper
• The accuracy of clinical neck staging for p16-positive and negative oropharyngeal cancer and its therapeutic implications

  2022cites this paper
• Patienten-Benefit und Lebensqualität nach Roboter-assistierten Operationen im Kopf-Hals-Bereich

  2022cites this paper
• Human papillomavirus-related oropharyngeal carcinoma.

  2022cites this paper
• Surgery alone for transorally resected human papillomavirus–driven head and neck cancer—can we de‐intensify adjuvant therapy to 0 Gy and 0 mg/m2?

  2021cites this paper
• Surgical margins in a single‐modality transoral robotic surgery: A conundrum—Reply

  2021cites this paper
• Identification of a minimal biomarker profile in head-and-neck squamous cell carcinoma tumors

  2021cites this paper
• Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer.

  2021cites this paper